These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22927141)

  • 21. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The in vivo topography of cortical changes in healthy aging and prodromal Alzheimer's disease.
    Prestia A; Baglieri A; Pievani M; Bonetti M; Rasser PE; Thompson PM; Marino S; Bramanti P; Frisoni GB
    Suppl Clin Neurophysiol; 2013; 62():67-80. PubMed ID: 24053032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic resonance imaging study cannot individually distinguish individuals with mild cognitive impairment, mild Alzheimer's disease, and normal aging.
    Menezes TL; Andrade-Valença LP; Valença MM
    Arq Neuropsiquiatr; 2013 Apr; 71(4):207-12. PubMed ID: 23588280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic differentiation of mild cognitive impairment due to Alzheimer's disease using a hippocampus-dependent test of spatial memory.
    Moodley K; Minati L; Contarino V; Prioni S; Wood R; Cooper R; D'Incerti L; Tagliavini F; Chan D
    Hippocampus; 2015 Aug; 25(8):939-51. PubMed ID: 25605659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fully Automated Atlas-Based Hippocampus Volumetry for Clinical Routine: Validation in Subjects with Mild Cognitive Impairment from the ADNI Cohort.
    Suppa P; Hampel H; Spies L; Fiebach JB; Dubois B; Buchert R;
    J Alzheimers Dis; 2015; 46(1):199-209. PubMed ID: 25720402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of Alzheimer's disease and mild cognitive impairment using cortical morphological patterns.
    Wee CY; Yap PT; Shen D;
    Hum Brain Mapp; 2013 Dec; 34(12):3411-25. PubMed ID: 22927119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment.
    Chételat G; Desgranges B; De La Sayette V; Viader F; Eustache F; Baron JC
    Neuroreport; 2002 Oct; 13(15):1939-43. PubMed ID: 12395096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural MRI biomarkers for preclinical and mild Alzheimer's disease.
    Fennema-Notestine C; Hagler DJ; McEvoy LK; Fleisher AS; Wu EH; Karow DS; Dale AM;
    Hum Brain Mapp; 2009 Oct; 30(10):3238-53. PubMed ID: 19277975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort.
    Risacher SL; Saykin AJ; West JD; Shen L; Firpi HA; McDonald BC;
    Curr Alzheimer Res; 2009 Aug; 6(4):347-61. PubMed ID: 19689234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cortical surface mapping using topology correction, partial flattening and 3D shape context-based non-rigid registration for use in quantifying atrophy in Alzheimer's disease.
    Acosta O; Fripp J; Doré V; Bourgeat P; Favreau JM; Chételat G; Rueda A; Villemagne VL; Szoeke C; Ames D; Ellis KA; Martins RN; Masters CL; Rowe CC; Bonner E; Gris F; Xiao D; Raniga P; Barra V; Salvado O
    J Neurosci Methods; 2012 Mar; 205(1):96-109. PubMed ID: 22226742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinguishing early and late brain aging from the Alzheimer's disease spectrum: consistent morphological patterns across independent samples.
    Doan NT; Engvig A; Zaske K; Persson K; Lund MJ; Kaufmann T; Cordova-Palomera A; Alnæs D; Moberget T; Brækhus A; Barca ML; Nordvik JE; Engedal K; Agartz I; Selbæk G; Andreassen OA; Westlye LT;
    Neuroimage; 2017 Sep; 158():282-295. PubMed ID: 28666881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An MRI-based index to measure the severity of Alzheimer's disease-like structural pattern in subjects with mild cognitive impairment.
    Spulber G; Simmons A; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Spenger C; Lovestone S; Wahlund LO; Westman E;
    J Intern Med; 2013 Apr; 273(4):396-409. PubMed ID: 23278858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters.
    Lindemer ER; Salat DH; Smith EE; Nguyen K; Fischl B; Greve DN;
    Neurobiol Aging; 2015 Sep; 36(9):2447-57. PubMed ID: 26095760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Asymmetrical White Matter Hyperintensities and Apolipoprotein E4 on Cognitive Impairment.
    Low A; Ng KP; Chander RJ; Wong B; Kandiah N
    J Alzheimers Dis; 2019; 70(3):953-964. PubMed ID: 31306121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
    Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
    Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MRI hippocampal and entorhinal cortex mapping in predicting conversion to Alzheimer's disease.
    Devanand DP; Bansal R; Liu J; Hao X; Pradhaban G; Peterson BS
    Neuroimage; 2012 Apr; 60(3):1622-9. PubMed ID: 22289801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of Alzheimer's disease using individual structural connectivity networks.
    Shao J; Myers N; Yang Q; Feng J; Plant C; Böhm C; Förstl H; Kurz A; Zimmer C; Meng C; Riedl V; Wohlschläger A; Sorg C
    Neurobiol Aging; 2012 Dec; 33(12):2756-65. PubMed ID: 22405045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. White matter lesion load is associated with resting state functional MRI activity and amyloid PET but not FDG in mild cognitive impairment and early Alzheimer's disease patients.
    Zhou Y; Yu F; Duong TQ;
    J Magn Reson Imaging; 2015 Jan; 41(1):102-9. PubMed ID: 24382798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disentangling normal aging from Alzheimer's disease in structural magnetic resonance images.
    Lorenzi M; Pennec X; Frisoni GB; Ayache N;
    Neurobiol Aging; 2015 Jan; 36 Suppl 1():S42-52. PubMed ID: 25311276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complexity analysis of cortical surface detects changes in future Alzheimer's disease converters.
    Ruiz de Miras J; Costumero V; Belloch V; Escudero J; Ávila C; Sepulcre J
    Hum Brain Mapp; 2017 Dec; 38(12):5905-5918. PubMed ID: 28856799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.